Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

Children's Oncology Group · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
recurrent acute myeloid leukemia, refractory acute myeloid leukemia, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 885352
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.